UNLABELLED: There are several murine models described with features similar to human primary biliary cirrhosis (PBC). Among these models, the one which has the closest serologic features to PBC is a mouse with a T-cell-restricted expression of the dominant negative transforming growth factor β receptor type II (dnTGFβRII). Our work has demonstrated that CD8(+) T cells from dnTGFβRII mice transfer autoimmune cholangitis to Rag1(-/-) recipients. However, it remained unclear whether the autoimmune cholangitis was secondary to an intrinsic function within CD8(+) T cells or due to the abnormal TGFβR environment within which CD8(+) T cells were generated. To address this mechanistic issue, we used our dnTGFβRII, OT-I/Rag1(-/-) , OT-II/Rag1(-/-) mice and in addition generated OT-I/dnTGFβRII/Rag1(-/-) , and OT-II/dnTGFβRII/Rag1(-/-) mice in which the entire T-cell repertoire was replaced with ovalbumin (OVA)-specific CD8(+) or CD4(+) T cells, respectively. Importantly, neither the parental OT-I/dnTGFβRII/Rag1(-/-) mice and/or OT-II/dnTGFβRII/Rag1(-/-) mice developed cholangitis. However, adoptive transfer demonstrated that only transfer of CD8(+) T cells from dnTGFβRII mice but not CD8(+) T cells from OT-I/Rag1(-/-) mice or from OT-I/dnTGFβRII/Rag1(-/-) mice transferred disease. These data were not secondary to an absence of CD4(+) T cell help since a combination of CD8(+) T cells from OT-I/dnTGFβRII/Rag1(-/-) and CD4(+) T cells from OT II/dnTGFβRII/Rag1(-/-) or CD8(+) T cells from OT-I/dnTGFβRII/Rag1(-/-) with CD4(+) T cells from OT-II/Rag1(-/-) mice failed to transfer disease. CONCLUSION: Defective TGFβRII signaling, in addition to clonal CD8(+) T cells that target biliary cells, are required for induction of autoimmune cholangitis.
UNLABELLED: There are several murine models described with features similar to humanprimary biliary cirrhosis (PBC). Among these models, the one which has the closest serologic features to PBC is a mouse with a T-cell-restricted expression of the dominant negative transforming growth factor β receptor type II (dnTGFβRII). Our work has demonstrated that CD8(+) T cells from dnTGFβRII mice transfer autoimmune cholangitis to Rag1(-/-) recipients. However, it remained unclear whether the autoimmune cholangitis was secondary to an intrinsic function within CD8(+) T cells or due to the abnormal TGFβR environment within which CD8(+) T cells were generated. To address this mechanistic issue, we used our dnTGFβRII, OT-I/Rag1(-/-) , OT-II/Rag1(-/-) mice and in addition generated OT-I/dnTGFβRII/Rag1(-/-) , and OT-II/dnTGFβRII/Rag1(-/-) mice in which the entire T-cell repertoire was replaced with ovalbumin (OVA)-specific CD8(+) or CD4(+) T cells, respectively. Importantly, neither the parental OT-I/dnTGFβRII/Rag1(-/-) mice and/or OT-II/dnTGFβRII/Rag1(-/-) mice developed cholangitis. However, adoptive transfer demonstrated that only transfer of CD8(+) T cells from dnTGFβRII mice but not CD8(+) T cells from OT-I/Rag1(-/-) mice or from OT-I/dnTGFβRII/Rag1(-/-) mice transferred disease. These data were not secondary to an absence of CD4(+) T cell help since a combination of CD8(+) T cells from OT-I/dnTGFβRII/Rag1(-/-) and CD4(+) T cells from OT II/dnTGFβRII/Rag1(-/-) or CD8(+) T cells from OT-I/dnTGFβRII/Rag1(-/-) with CD4(+) T cells from OT-II/Rag1(-/-) mice failed to transfer disease. CONCLUSION: Defective TGFβRII signaling, in addition to clonal CD8(+) T cells that target biliary cells, are required for induction of autoimmune cholangitis.
Authors: Yugo Ando; Guo-Xiang Yang; Masanobu Tsuda; Kazuhito Kawata; Weici Zhang; Takahiko Nakajima; Koichi Tsuneyama; Patrick Leung; Zhe-Xiong Lian; Kazuichi Okazaki; William M Ridgway; Gary L Norman; Aftab A Ansari; Xiao-Song He; Ross L Coppel; M Eric Gershwin Journal: Hepatology Date: 2012-10 Impact factor: 17.425
Authors: Guanghua Rong; Renqian Zhong; Ana Lleo; Patrick S C Leung; Christopher L Bowlus; Guo-Xiang Yang; Chen-Yen Yang; Ross L Coppel; Aftab A Ansari; Dean A Cuebas; Howard J Worman; Pietro Invernizzi; Gregory J Gores; Gary Norman; Xiao-Song He; M Eric Gershwin Journal: Hepatology Date: 2011-07 Impact factor: 17.425
Authors: Ana Lleo; Carlo Selmi; Pietro Invernizzi; Mauro Podda; Ross L Coppel; Ian R Mackay; Gregory J Gores; Aftab A Ansari; Judy Van de Water; M Eric Gershwin Journal: Hepatology Date: 2009-03 Impact factor: 17.425
Authors: Masanobu Tsuda; Weici Zhang; Guo-Xiang Yang; Koichi Tsuneyama; Yugo Ando; Kazuhito Kawata; Ogyi Park; Patrick S C Leung; Ross L Coppel; Aftab A Ansari; William M Ridgway; Bin Gao; Zhe-Xiong Lian; Richard Flavell; Xiao-Song He; M Eric Gershwin Journal: Hepatology Date: 2013-02 Impact factor: 17.425
Authors: Jijing Tian; Guoxiang Yang; Huan-Yuan Chen; Daniel K Hsu; Alexey Tomilov; Kristin A Olson; Ali Dehnad; Sarah R Fish; Gino Cortopassi; Bin Zhao; Fu-Tong Liu; M Eric Gershwin; Natalie J Török; Joy X Jiang Journal: FASEB J Date: 2016-09-14 Impact factor: 5.191
Authors: Jinjun Wang; Guoxiang Yang; Alana Mari Dubrovsky; Jinjung Choi; Patrick S C Leung Journal: World J Gastroenterol Date: 2016-01-07 Impact factor: 5.742
Authors: H Tanaka; G-X Yang; T Tomiyama; K Tsuneyama; W Zhang; P S C Leung; R L Coppel; T Joh; S G Nadler; A A Ansari; C Bowlus; M E Gershwin Journal: Clin Exp Immunol Date: 2015-06 Impact factor: 4.330
Authors: Patrick S C Leung; Jinjung Choi; Guoxiang Yang; Elena Woo; Thomas P Kenny; M Eric Gershwin Journal: Expert Rev Mol Diagn Date: 2016-03-30 Impact factor: 5.225
Authors: Wenting Huang; Kritika Kachapati; David Adams; Yuehong Wu; Patrick S C Leung; Guo-Xiang Yang; Weici Zhang; Aftab A Ansari; Richard A Flavell; M Eric Gershwin; William M Ridgway Journal: J Autoimmun Date: 2014-02-18 Impact factor: 7.094
Authors: C-H Chang; Y-C Chen; Y-H Yu; M-H Tao; P S C Leung; A A Ansari; M E Gershwin; Y-H Chuang Journal: Clin Exp Immunol Date: 2014-08 Impact factor: 4.330